FindTrial
Sign In

Performance repeatability, reproducibility, and agreement of the EyeRobo RHDE-III ocular surface (Dry eye) diagnostic device in healthy adults

Performance repeatability, reproducibility, and agreement of the EyeRobo RHDE-III ocular surface (Dry eye) diagnostic device in healthy adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110768
Enrollment
Unknown
Registered
2025-10-20
Start date
2025-10-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Observational group:None

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Healthy adults aged 18–35 years, with best-corrected visual acuity =20/20, and confirmed through screening to have healthy ocular surfaces and ocular structures (no history of ocular surgery, no active or past ocular diseases, no corneal staining, and no systemic conditions or contraindications that could affect the ocular surface or interfere with measurements).

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The 11 key quantitative outputs of EyeRobo RHDE-III include tear film breakup time, meibomian gland imaging, tear meniscus height, lipid layer assessment, lid margin evaluation, iris measurement, two red-eye analyses, inflammation assessment, ocular surface observation, and questionnaire.;—

Countries

China

Contacts

Public ContactRen Xinjun

Tianjin Medical University Eye Hospital

zlrxjrsy@126.com+86 22 86428838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026